|Publication number||WO2002025277 A1|
|Publication date||28 Mar 2002|
|Filing date||24 Sep 2001|
|Priority date||22 Sep 2000|
|Publication number||PCT/2001/701, PCT/NL/1/000701, PCT/NL/1/00701, PCT/NL/2001/000701, PCT/NL/2001/00701, PCT/NL1/000701, PCT/NL1/00701, PCT/NL1000701, PCT/NL100701, PCT/NL2001/000701, PCT/NL2001/00701, PCT/NL2001000701, PCT/NL200100701, WO 0225277 A1, WO 0225277A1, WO 2002/025277 A1, WO 2002025277 A1, WO 2002025277A1, WO-A1-0225277, WO-A1-2002025277, WO0225277 A1, WO0225277A1, WO2002/025277A1, WO2002025277 A1, WO2002025277A1|
|Inventors||Gheorghe Aurel Marie Pop|
|Applicant||Martil Instruments B.V.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (4), Non-Patent Citations (1), Referenced by (45), Classifications (9), Legal Events (9)|
|External Links: Patentscope, Espacenet|
HEART-LUNG MACHINE PROVIDED WITH A DEVICE FOR ELECTRICAL IMPEDANCE MEASUREMENT ,
AND METHOD THEREFORE
The present invention relates to a blood transporting machine as according to the heading of claim 1.
A blood transporting machine is used for extracorpo- real circulation of blood. Examples hereof are a heart- lung machine and an artificial kidney machine.
An open-heart operation is usually performed with a heart-lung machine (HLM) . Cerebral dysfunction and to a lesser extent kidney function disorders are frequently occurring problems for patients as a result of this operation. These cerebral and renal problems not only cause a greater or lesser degree of permanent invalidity for the patient, but also result in hospital accommodation costs in the short term and costs of care in the longer term.
One of the causes of renal and cerebral disorders is formed by a rise in the viscosity of the blood, which is caused by hypothermia and by the "acute phase" reaction generated in the body by the operation. Increased viscosity is linked to reduced cerebral microcirculation. Hyperviscosity resulting from hypothermia affects the renal function. In addition, the moments of canulating, manipulation of the heart and declamping of the aorta are significant surgical sources of the occurrence of micro- embolisms. Despite the use of different filters in conjunction with the HLM, a significant part of the micro- embolisms is still found to occur as a result of perfusi- on problems associated with the HLM.
The present invention has for its object to monitor the viscosity of blood when it is transported extracorpo- really by a blood transporting machine.
This objective is achieved with the present invention by providing a blood transporting machine of the above stated type, further comprising means for processing the impedance value to a viscosity value. The blood viscosity of a patient being treated can be measured with the blood transporting machine according to the invention.
It is favourable to embody the blood transporting machine as according to claim 2. It is hereby possible to monitor the blood viscosity value during open-heart operations. When the recorded blood viscosity value changes in adverse manner, external intervention can take place, for instance with medication.
Claim 3 is preferably applied. The electrical impe- dance measurement in the blood hereby takes place as soon as it is transported out of the blood transporting machine. A viscosity value for the blood is hereby obtained in a short time.
Claim 4 is preferably applied. Measuring of the impedance of the blood hereby becomes possible in efficient manner.
According to claim 5 the blood transporting machine is preferably embodied with a set of measuring electrodes . The impedance of the blood can hereby be measured between the measuring electrodes.
In the preferred embodiment the electrodes are circular. Such an embodiment allows the electrodes to enclose the perfusion tube.
The blood transporting machine is preferably embo- died with platinum electrodes. The use of platinum electrodes has a favourable effect on the accuracy of the value determination of the viscosity of the blood.
The electrodes are preferably arranged at a regular distance from each other in the longitudinal direction of the perfusion tube. A homogeneous electrical field in the blood is hereby achieved.
It is favourable to embody the heart-lung machine as according to claim 9. Such a ratio is effective for the homogeneity of the electrical field to be applied and measured.
The measure as according to claim 10 has a favourable effect on the accuracy of the measurement of the impedance value, and therefore on the accuracy of the blood viscosity to be determined.
In a preferred embodiment according to the invention the measure of claim 11 is applied in the blood transpor- ting machine. Particular medications administered to a patient when blood is circulated outside the body influence the sodium concentration in the blood of the patient. The sodium concentration influences the impedance of the blood. Inclusion of the sodium concentration in the algorithm for processing the impedance signal produces a more accurate determination of the viscosity value of the blood.
The invention also relates to and provides a.method for the operation of the heart-lung machine according to the invention. The method according to the invention relates in particular to detecting embolisms in the blood.
The method according to the invention preferably comprises of detecting air embolisms and/or micro-embo- lisms.
In a preferred embodiment according to the invention the blood transporting machine is embodied with temperature measuring means and means for measuring the haemato- crit value of the blood. These values can hereby also be monitored. The relation between the electrical impedance of the blood and the viscosity depends on the temperature and is also determined by the haematocrit value. For processing of the impedance signal to a viscosity value a calculation of the impedance signal is necessary with an algorithm dependent on the temperature and the haematocrit value.
It is favourable to determine correlation values for the relation between impedance of the blood and viscosity in relation to the temperature and the haematocrit value. The correlation coefficients are determined by doing an experiment with a large group of people. These are incorporated in the algorithm for processing the impedance signal to a viscosity value. An apparatus and a method for detecting the presence of embolisms in a tube through which blood or other fluid flows using a blood impedance measuring system is otherwise known from US 4,014,206. The invention is further elucidated with reference to the annexed figures, in which:
Figure 1 shows a schematic view of a preferred embodiment of the device for electrical impedance measurement of the blood in a heart-lung machine; Figure 2 shows a graph of a measurement signal for the impedance with the embodiment of figure 1 ;
Figure 3 shows a graph of an example of change in the impedance in accordance with a measurement with the embodiment of figure 1; Figure 4 shows a schematic view of a device for electrical impedance measurement of the blood, wherein particles flow in the blood;
Figure 5 shows a graph of the relation between impedance and viscosity corrected according to the inven- tion.
Figure 1 shows a schematic view of a preferred embodiment of the measuring device 1 for electrical impedance measurement of the blood in a blood transporting machine. The measuring device of the blood transpor- ting machine comprises two outer current electrodes 2,3 and two inner measuring electrodes 4,5 in the perfusion tube 6, immediately after the source from the blood transporting machine. Electrodes 2-5 are preferably circular and of platinum or stainless steel with a layer of precious metal. In order to obtain a homogeneous electrical field the distances between electrodes 2-5 are chosen so as to be more than twice the diameter of the perfusion tube 6 coming out of the blood transporting machine. By generating a low alternating current (10mA - 1mA) with a frequency between 4 kHz and 5000 kHz with an alternating current source 7 via the two outer electrodes 2,3, it will be possible via measuring electrodes 4,5 to continuously measure an impedance (ZO) of the blood passing the measuring electrodes. The impedance is acquired by measuring means 8.
Also shown is a sodium concentration measuring means 9 which is arranged in perfusion tube 6. Processing means 10 processes the measured value to a blood viscosity value which can be shown on a screen 11. The processing means can also be embodied to detect the occurrence of embolisms in the blood, air and/or micro-embolisms in particular. An example of an impedance signal as measured with the embodiment of figure 1 is shown in figure 2. A continuous recording of the change in the impedance signal (delta Z) can likewise take place. An example of a measurement signal of the change in the impedance signal is shown in figure 3.
It is known that blood has electrical properties. These electrical properties differ for plasma and blood cells. The plasma and the interior of the cells consist of conducting fluids with a determined electrical resis- tance and cell membranes consist of phospholipids and proteins with di-electrical properties. The electrical impedance of blood is determined primarily by three parameters: plasma resistance, internal resistance in the cell and the capacitance of the cell membrane. The elec- trical impedance of the blood increases with an increased viscosity of the blood. Just as the viscosity, the electrical impedance of blood increases during hypothermia and this is determined to a large degree by the haematocrit . Small particles (< 100 micron) with an impedance other than blood will become manifest in a sudden change in the impedance signal (Figures 2 + 3) . These changes can be seen particularly in the deltaZ signal and the magnitude of this change depends on the difference in specific resistance of the particles and of blood. During passage of air particles a large deflection will occur in the deltaZ signal in view of the clearly higher specific resistance of air relative to blood. This deflection of
H- tr rr tr ϋ 3 CO rt Ω <! H- g o φ rt z ?r rt Ω H- 3 SD o TJ rt μ- TJ rt CQ 0 m SD CQ TJ rt g Φ H Φ Φ H- 3" SD Φ 3 Φ K tr μ- 3 tr 3 Φ ϋ 3 ϋ tr φ • ϋ μ- d 3 3- g SD tr
TJ rt SD rt CQ i LQ Φ rt CQ 3 o Φ Φ O φ Φ rt Ω 1—1. CQ 0 K SD Φ O Ω Ω Φ SD ϋ Φ
Φ Z rt Z Φ H- 3 H- rt e rt Ω z CQ 0 Φ d tr o ? • <! CQ tr ^ Φ rt
U Φ H- Φ SD Ω H- 0 O Φ Φ CQ z rt *ϋ 3 Ω CQ CQ 0 h-1 g SD μ- Si CQ μ- Si w Φ O Φ ti S l-h rt 3 CO SD H- > ϋ SD SD 0 ≤ rt ≥; CQ rt Hi Φ r LQ Z Pi 0 SD μ- Φ CQ Ω φ
3 3 3 3 Ω rt H- * CQ rt P 0 rr 3 0 ii -> rt 3 H- tr 0 SD Φ 3 0 φ tr Φ Hi CQ 3 Hi φ Ω
Ω - K- Ω Φ CQ Ω 3^ 0 Pi rt CQ 1 rt rt Φ rt H P. CQ rt Φ i ϋ Φ rt
Φ rt 0 rt 0 SD M o 0 Ω rt Φ H- 0 Φ H- tr ^ 3 Z H- μ- rt μ- rt 3 μ- Φ 0 CQ SD
3- l-h 3* tr 3 3 3 tr Hi d tn tr CQ Ω 3 TJ O SD H- Ω 3 3* 3 tr μ- Ω Ω ϋ rt IS,
0 Φ Φ SD rt P. SD ϋ tr1 Φ TJ rt d H- i 3 rt SD Φ CQ φ Ω SD rt φ CQ 0 l-h Hi CQ CQ d rt < 3^ CQ 3 ϋ . — . Φ ϋ 0 0 3 Φ 0 3 h-1 3 rt ii μ- H rt μ- LQ - Hi CQ
H- H- 3 d ^ ti tr Φ φ CQ 0 rf TJ CQ ^ Si SD ^ LQ μ- 0 Φ 0 ii μ- tr 3 tr φ CQ Ω H- φ TJ Z tr 3 Φ TJ < SD CQ Φ Φ CQ rt tr rt Φ rt tr 3 1 3 φ rt 0 LQ
TJ SD ^ 3* h 3 CQ SD tr ^ Φ Φ SD H- i 3 Ω Φ H- tr Φ Φ tr rt TJ Φ Z φ tr rt 3
0 φ H- CQ 0 0 LQ 0 tr H Φ rt H Pi Hi SD Ω SD SD 3 ii i TJ φ φ g tr 0 Φ tr SD
0 Si 3 d z SD M 3 0 H- 3 g ^ •x] SD Φ rt 3 φ 3 Hi o μ- Φ ti μ- Si CJ1 Φ Hi Hi Φ u PJ 0 t 3 CQ SD Φ S 3 Φ 0 H- H- 0 Ω Ω rt Φ SD ϋ Φ 3 SD 0 rt ti CO ti
3 LQ Φ 3* 3 3 Mi SD P. LQ h-1 CQ 3 z Φ 0 rt tr tr * ii M rt 3 tr rt o TJ z
C Ω Φ α rt Φ tr SD H- 3 d φ 0 φ ϋ 3" Φ H- ^ . d SD 0 Ω μ- Φ 3- 3 φ Ω μ- φ Φ 3 tr 3 TJ O Qi rt CQ tr CQ O ii 3 CQ O Φ Ml CQ ϋ Φ CQ ii Φ Ω 0
Ω H- SD Ω SD 13 3 tr ii Ml Φ φ 0 TJ rt 0 0 Ω rt ϋ H μ- Φ rt 3 rt μ- 3 u SD rt 3 r ti H Φ si. SD SD H- 0 rt Hi Φ tr rt H- M SD !-r H- 3 0 tr SD CQ 0 μ- t Hl CQ
Φ 3 - TJ O H- 3 rt 3 3 Ml 3 ι . O H- Φ Φ tr 3 CQ Φ Hi 3 SD Φ rt ii 3 Φ μ- μ- tr
SD u SD φ ΓT Si 3 SD rt 0 0 — 3 Ω u ϋ Φ TJ l-1 φ Hi tr μ- tr TJ Ω CQ φ
CD rt 3" tr 3 rt H- LQ 0 3 rt Mi 3 ii Φ Φ SD Φ o CQ ii Ω 3 φ CQ rt
Φ r SD Φ SD Φ u tr Ω Φ 3 μ- tr 0 SD rt rt Z Si SD SD 3 ii rt ; 0 μ- rt 0 TJ H Φ O - H- 3 i H 3 SD Φ O 3 rt Φ H 3 tr tr H- SD >r H- rt Φ tr CQ Φ 3 Hi ^ rt SD Φ Φ 3 φ
Φ CQ Ω Φ SD P. M tr SD h-1 0 3 LQ ϋ SD CQ 3 SD ϋ H- 3 rt CD Hi 3 Ω CQ Ω CQ
SD Φ ϋ rt SD Ω LQ ii H- ϋ SD φ o 3 Φ Ω LQ Ω rt Ω Φ ζ μ- φ σ CQ Ω μ- μ- ■<! CQ
CQ TJ H- SD φ tr d Φ 3 H- H- rt d Φ φ H- 0 • SD 3 0 CQ ϋ ^ 3 φ Hi CQ
H- M 0 CQ H- 0 3 SD P- Φ 3 3 H- H- LQ rt SD CQ SD CQ rt φ SD μ- rt LQ rt CQ Φ Hi Φ Mi TJ o 3 SD d LQ φ 0 3 tr tr 3 CQ H- LQ ≤ Φ 0 μ- Φ 3 3 CQ Ω SD CQ ii tr Ω CQ SD ti H- Φ H Ω rt Ω tr 3 SD α !-■• 3 TJ d tr CQ H CO 3 rt φ μ- 3 d Φ φ O Φ tr tr H H φ H- H- P- rt tr rt rt rt LQ ϋ Φ 3 Ω SD LQ ii Ω Ω SD
CQ 3 tr H- M SD 3* 0 3 0 3J Φ SD tr tr Ω 3 rt Φ SD 3 r 3 CQ Hi 3 TJ 3 Φ φ tr rt
<! μ- ft 0 H- 3 μ- rt SD 0 3 LQ 1 Φ rt tr φ Φ 0 0 SD tr CQ 3 tr μ- ϋ CQ SD SD CO
H- rt •> 0 CQ 3 H- LQ Hi H- z 0 Mi 3 Φ Φ rt rt Φ Ω ϋ 0 Φ ϋ μ- 0 SD P. O ■ ; P- ? < o 0 H- rt SD 3 Ω φ d H- TJ CQ 3 tr ii d H) lP o rt CQ Hi CQ d
Ω D H- LQ 3 Ω rt 3J LQ T3 O φ rt 3 Φ tr H- TJ TJ rt s: Φ rt 0 Φ d Hi μ- Z rt ϋ
0 0 3 SD Ω rt Φ tr Φ Φ Φ SD 3 TJ i CQ ii Φ H- ϋ i 1 rt Φ Ω μ- SD Z μ- μ-
CQ l-h fi 3 0 H 3 ϋ Ω t f 3 Si LQ rt φ Hi 0 rt 0 i H- I-1 φ Φ Φ rt tr 3 rt 3 tr t- 3
H- u H. o 1 0 0 0 SD rt SD C rt tr Pi c 0 Φ ! Hi rt I-" SD 3 0 Φ Ω tr Φ I-" Ω μ- LQ rt rt rt H ϋ Φ 3 3 TJ CQ 3 tr Φ SD CQ Pi 3 H- C SD rt t CO μ- φ CQ φ Ω rt
^ 3J tr rt Φ tr Φ CQ TS tr ^ Ω SD Φ 3 H- Ω i CQ Z 3' ϋ 3 o Hi Φ φ rt 3* 3* TJ
Φ Φ t H- α -~ 0 SD φ rt Ω 0 ^ Φ μ- H- SD φ Φ 0 CQ Ω SD tr 0 Φ SD
SD ii Φ SD 0 d 3 H- rt ii H- 3 H- Φ 3 tr ■ 0 h-1 < 3 μ- ii TJ - tr i φ Hi Si CQ
3 tr φ rt Ω 0 Ω μ- O Φ 3 0 Φ SD 0 H- 3 Φ H- rt CQ SD SD φ ii μ- Ω CQ
Pi Mi Ω H- H- H- rt SD Ω 0 Φ 3 SD 3 CQ rt rt Mi 3 3 3 μ- ϋ Z H φ tr Hi SD SD
0 0 o 0 3 3 et g d SD CQ φ H- d CQ CQ tr rt Pi 0 CQ 3 rt μ- SD TJ Hi Hi CQ LQ
Ω 0 H 3 3 TS LQ H- Ω TS CQ CQ P. d rt LQ tr Z TJ H- ^ Φ 0 H- Mi CQ μ- Ω SD 0 0 φ Φ Φ
0 u Φ Ω φ H- 0 0 SD Φ d d ii Φ 3 Φ tr 'SD LQ CQ Ω 0 rt Ω -> rt CQ ii 0 ti
3 • Φ Si Mi 3 3 i P. ii ϋ H- ii SD CQ Φ ii 3" rt σ SD rt Hi SD φ CQ Φ i CQ 0 0
Ω 3 SD Hi CQ TS SD φ H- 3 3 rt rt Φ φ rt 3- 3 Φ SD ϋ μ- Hi Hi
Φ Hi 1 3 Φ rt 3 LQ O H- H- 3 H- Φ Ω CQ I-1 μ- 3 3 rt
3 tr Ω H 0 H- H- LQ Mi CQ φ "* CQ CQ iQ 0 0 Φ Φ 3 0 1 rt
Ω ϋ μ- rt
According to the invention a relation can be formulated between the viscosity value, the electrical impedance, the haematocrit value, the. temperature and the sodium level in the blood. The latter three factors influence the impedance of the blood. A test arrangement with blood from ten volunteers was used to establish correlation coefficients for said relation. The test arrangement simulated a heart-lung machine. Gelofusine was also added to change the haematocrit value. It was found that:
(1) Ln (visco) = 0.774 + 2876 x 10"2 x HCT - 2.104 x 10"2 x T + 2.765 x 10"3 X Na.
(2) Ln (imp.) = 5.466 + 2.386 x 10"2 x HCT - 1.961 x 10"2 x T - 5.995 x 10"3 x Na. (3) Visco = 0.364 + 3.782 x 10"2 x imp., wherein Ln is the natural logarithm, visco is the viscosity value, HCT the haematocrit value, T the temperature, Na the sodium level, and imp. the impedance according to the measurement. Measurement took place in the test arrangement with an alternating current with a frequency of 20 kHz and an alternating current value of 300 μA.
During the test arrangement the levels of Ht, sodium, potassium, calcium and the pH were measured. Of these variables only the sodium was found to have significant influence on the impedance/viscosity. For the processing of the impedance measurement to a viscosity value a correction is therefore necessary which depends on the measured sodium concentration.
The third formula shows a direct correlation between the viscosity value and the impedance measurement.
In figure 5 is shown the correlation between the viscosity and the impedance of a test measurement with the blood of ten people. The viscosity and impedance are shown to be correlated. The measurement of the impedance can be used to determine the viscosity value. The processing means are provided with an algorithm which calculates the relation according to formula (3) , wherein a correction for the measured sodium concentration is also carried out .
|Cited Patent||Filing date||Publication date||Applicant||Title|
|WO2000074775A1 *||5 Jun 2000||14 Dec 2000||Martil Instruments B.V.||Method, device and catheter for in vivo determining blood properties such as blood viscosity|
|EP0542140A2 *||6 Nov 1992||19 May 1993||Fresenius AG||Tube arrangement for use in a blood circuit|
|US4014206||31 Mar 1975||29 Mar 1977||Akron City Hospital||Apparatus and method for monitoring air emboli during extracorporeal circulation|
|US4835477 *||14 Aug 1987||30 May 1989||Fresenius Ag||Process for the determination of the hematocrit level of whole blood and apparatus for carrying out the process|
|1||*||VRIES DE P M J M ET AL: "IMPLICATIONS OF THE DIELECTRICAL BEHAVIOUR OF HUMAN BLOOD FOR CONTINUOUS ONLINE MEASUREMENT OF HAEMATOCRIT", MEDICAL AND BIOLOGICAL ENGINEERING AND COMPUTING,GB,PETER PEREGRINUS LTD. STEVENAGE, vol. 31, no. 5, 1 September 1993 (1993-09-01), pages 445 - 448, XP000400532, ISSN: 0140-0118|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|WO2005059532A1 *||16 Dec 2003||30 Jun 2005||Dynabyte Informationssysteme Gmbh||Cartridge device for blood analysis|
|WO2011144511A1 *||11 May 2011||24 Nov 2011||Fresenius Medical Care Deutschland Gmbh||Method and apparatus for determining cellular and/or extracellular, in particular macromolecular, portions of fluids, preferably bodily fluids, of living beings|
|WO2014162285A1 *||3 Apr 2014||9 Oct 2014||Universita' Degli Studi Di Udine||Apparatus for analyzing the process of formation of aggregates in a biological fluid and corresponding method of analysis|
|WO2016152304A1 *||12 Feb 2016||29 Sep 2016||ソニー株式会社||Blood state monitoring device, method for monitoring blood state, blood state monitoring system, and blood state improving program|
|EP2187201A1 *||16 Dec 2003||19 May 2010||Dynabyte Informationssysteme GmbH||Cartridge device for blood analysis|
|US7901629||16 Dec 2003||8 Mar 2011||Dynabyte Informationssysteme Gmbh||Cartridge device for blood analysis|
|US8388541||25 Nov 2008||5 Mar 2013||C. R. Bard, Inc.||Integrated system for intravascular placement of a catheter|
|US8388546||21 Apr 2009||5 Mar 2013||Bard Access Systems, Inc.||Method of locating the tip of a central venous catheter|
|US8393208||8 Oct 2010||12 Mar 2013||Meggitt (New Hampshire), Inc.||Measuring of fluid in a vessel with two coaxial cable sections and a coupling therebetween using time domain reflectometry|
|US8437833||7 Oct 2009||7 May 2013||Bard Access Systems, Inc.||Percutaneous magnetic gastrostomy|
|US8465978||17 Feb 2011||18 Jun 2013||F. Hoffmann-La Roche Ag||Method for conducting platelete aggregation analysis by a cartridge device|
|US8478382||11 Feb 2009||2 Jul 2013||C. R. Bard, Inc.||Systems and methods for positioning a catheter|
|US8512256||9 Sep 2010||20 Aug 2013||Bard Access Systems, Inc.||Method of locating the tip of a central venous catheter|
|US8549909||14 Apr 2011||8 Oct 2013||Meggitt (Orange County), Inc.||Vessel probe connector with solid dielectric therein|
|US8591816||17 Feb 2011||26 Nov 2013||F. Hoffmann-La Roche Ag||Cartridge device for blood analysis|
|US8774907||9 Jan 2013||8 Jul 2014||Bard Access Systems, Inc.||Method of locating the tip of a central venous catheter|
|US8781555||2 Mar 2010||15 Jul 2014||C. R. Bard, Inc.||System for placement of a catheter including a signal-generating stylet|
|US8784336||23 Aug 2006||22 Jul 2014||C. R. Bard, Inc.||Stylet apparatuses and methods of manufacture|
|US8794063||3 Dec 2009||5 Aug 2014||Meggitt (Orange County), Inc.||System and method for optimizing sweep delay and aliasing for time domain reflectometric measurement of liquid height within a tank|
|US8801693||27 Oct 2011||12 Aug 2014||C. R. Bard, Inc.||Bioimpedance-assisted placement of a medical device|
|US8849382||10 Sep 2009||30 Sep 2014||C. R. Bard, Inc.||Apparatus and display methods relating to intravascular placement of a catheter|
|US8858455||16 Aug 2013||14 Oct 2014||Bard Access Systems, Inc.||Method of locating the tip of a central venous catheter|
|US8877510||22 Nov 2013||4 Nov 2014||F. Hoffmann-La Roche Ag||Method for conducting platelet aggregation analysis|
|US8971994||8 Apr 2013||3 Mar 2015||C. R. Bard, Inc.||Systems and methods for positioning a catheter|
|US9125578||2 Feb 2011||8 Sep 2015||Bard Access Systems, Inc.||Apparatus and method for catheter navigation and tip location|
|US9211107||7 Nov 2012||15 Dec 2015||C. R. Bard, Inc.||Ruggedized ultrasound hydrogel insert|
|US9265443||5 May 2014||23 Feb 2016||Bard Access Systems, Inc.||Method of locating the tip of a central venous catheter|
|US9339206||14 Jun 2010||17 May 2016||Bard Access Systems, Inc.||Adaptor for endovascular electrocardiography|
|US9345422||3 Oct 2014||24 May 2016||Bard Acess Systems, Inc.||Method of locating the tip of a central venous catheter|
|US9415188||31 Jul 2014||16 Aug 2016||C. R. Bard, Inc.||Bioimpedance-assisted placement of a medical device|
|US9445734||10 Aug 2010||20 Sep 2016||Bard Access Systems, Inc.||Devices and methods for endovascular electrography|
|US9453755||1 Oct 2008||27 Sep 2016||Meggitt (Orange County), Inc.||TDR fluid level sensor|
|US9456766||27 May 2011||4 Oct 2016||C. R. Bard, Inc.||Apparatus for use with needle insertion guidance system|
|US9492097||6 Jul 2012||15 Nov 2016||C. R. Bard, Inc.||Needle length determination and calibration for insertion guidance system|
|US9521961||23 Dec 2011||20 Dec 2016||C. R. Bard, Inc.||Systems and methods for guiding a medical instrument|
|US9526440||19 Jun 2014||27 Dec 2016||C.R. Bard, Inc.||System for placement of a catheter including a signal-generating stylet|
|US9532724||22 Sep 2011||3 Jan 2017||Bard Access Systems, Inc.||Apparatus and method for catheter navigation using endovascular energy mapping|
|US9549685||26 Sep 2014||24 Jan 2017||C. R. Bard, Inc.||Apparatus and display methods relating to intravascular placement of a catheter|
|US9554716||27 May 2011||31 Jan 2017||C. R. Bard, Inc.||Insertion guidance system for needles and medical components|
|US9636031||29 Sep 2010||2 May 2017||C.R. Bard, Inc.||Stylets for use with apparatus for intravascular placement of a catheter|
|US9649048||17 Apr 2009||16 May 2017||C. R. Bard, Inc.||Systems and methods for breaching a sterile field for intravascular placement of a catheter|
|US9681823||11 May 2012||20 Jun 2017||C. R. Bard, Inc.||Integrated system for intravascular placement of a catheter|
|US20100153029 *||3 Dec 2009||17 Jun 2010||Vibro-Meter, Inc.||System and method for optimizing sweep delay and aliasing for time domain reflectometric measurement of liquid height within a tank|
|USD699359||1 Aug 2012||11 Feb 2014||C. R. Bard, Inc.||Ultrasound probe head|
|USD754357||24 Jan 2014||19 Apr 2016||C. R. Bard, Inc.||Ultrasound probe head|
|International Classification||G01N27/02, G01N33/487, G01N27/06, A61M1/36|
|Cooperative Classification||A61M1/3609, A61M2230/65, G01N27/02, A61M1/367|
|28 Mar 2002||AK||Designated states|
Kind code of ref document: A1
Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW
|28 Mar 2002||AL||Designated countries for regional patents|
Kind code of ref document: A1
Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG
|8 Aug 2002||DFPE||Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)|
|23 Oct 2002||121||Ep: the epo has been informed by wipo that ep was designated in this application|
|17 Mar 2003||WWE||Wipo information: entry into national phase|
Ref document number: 2001982926
Country of ref document: EP
|23 Apr 2003||WWW||Wipo information: withdrawn in national office|
Ref document number: 2001982926
Country of ref document: EP
|31 Jul 2003||REG||Reference to national code|
Ref country code: DE
Ref legal event code: 8642
|12 Nov 2003||122||Ep: pct application non-entry in european phase|
|13 Sep 2005||NENP||Non-entry into the national phase in:|
Ref country code: JP